Dutch medtech startup Ansana raises €850K to combat surgical site infections: Here’s how

Limburg, the Netherlands-based Ansana, a company specialised in sterilisation technology for the healthcare & pharmaceutical industry, announced on Wednesday that it has secured €850K from investors like NLC Health Ventures, LIOF, and Rabobank.  

The Dutch company will use the funds to develop alpha-prototypes, forge initial hospital collaborations, obtain ISO 13485 certification, progress EU and US regulatory strategies, and finalise its Go-to-Market strategy.

Dominique Surinx, CEO at Ansana, says, “This successful closing of Ansana’s seed round within an exceptionally short time frame, is a crucial milestone for the company and the team. It demonstrates the market confidence in Ansana’s solutions and value proposition. A clear support for our mission to improve patient lives around the globe.’’  

Annually, approximately 3M patients in Europe and the United States experience the impact of Surgical Site Infection (SSI). 

Research indicates that nearly 25 per cent of these infections stem from inadequate reprocessing of surgical instruments. 

During this procedure, over 115 million kilograms of plastic waste are produced in the United States alone.

Here’s where Dutch firm Ansana comes into play. 

Ansana: Sterilisation process management and control

Led by Dominique Surinx, Ansana develops innovative sterilisation technologies. 

The company’s patented container digitises and automates the sterilisation workflow of surgical tools. 

The container not only lowers the incidence of surgical site infections but also eliminates the necessity for consumables in the sterilisation process.

Moreover, the optimisation of the flows reduces the necessity for large inventories and improves service to the operating rooms. 

As a result, healthcare facilities experience a substantial reduction in the overall cost of ownership.

The investor

Rabobank is a cooperative bank that embraces innovation, growth, and sustainability.

Rabo Innovatielening is a loan for innovative startups that are improving sustainability in society or making it more digital, especially if they do not have cash flow or paying customers yet.

“Ansana’s simplified and sustainable technology, together with strong management, gives a perfect fit for the Rabo Innovation Loan,” says the Rabobank Startup & Scale-up team.